JP2018512408A5 - - Google Patents

Download PDF

Info

Publication number
JP2018512408A5
JP2018512408A5 JP2017549107A JP2017549107A JP2018512408A5 JP 2018512408 A5 JP2018512408 A5 JP 2018512408A5 JP 2017549107 A JP2017549107 A JP 2017549107A JP 2017549107 A JP2017549107 A JP 2017549107A JP 2018512408 A5 JP2018512408 A5 JP 2018512408A5
Authority
JP
Japan
Prior art keywords
triazolo
pyridin
benzonitrile
cyano
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017549107A
Other languages
English (en)
Japanese (ja)
Other versions
JP6726681B2 (ja
JP2018512408A (ja
Filing date
Publication date
Priority claimed from GBGB1504565.1A external-priority patent/GB201504565D0/en
Application filed filed Critical
Publication of JP2018512408A publication Critical patent/JP2018512408A/ja
Publication of JP2018512408A5 publication Critical patent/JP2018512408A5/ja
Application granted granted Critical
Publication of JP6726681B2 publication Critical patent/JP6726681B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017549107A 2015-03-18 2016-03-17 Phd阻害剤としての縮合二環式ヘテロアリール誘導体 Active JP6726681B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1504565.1 2015-03-18
GBGB1504565.1A GB201504565D0 (en) 2015-03-18 2015-03-18 Novel compounds
PCT/JP2016/059782 WO2016148306A1 (en) 2015-03-18 2016-03-17 Fused bicyclic heteroaryl derivatives having activity as phd inhibitors

Publications (3)

Publication Number Publication Date
JP2018512408A JP2018512408A (ja) 2018-05-17
JP2018512408A5 true JP2018512408A5 (enExample) 2019-04-25
JP6726681B2 JP6726681B2 (ja) 2020-07-22

Family

ID=53051992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017549107A Active JP6726681B2 (ja) 2015-03-18 2016-03-17 Phd阻害剤としての縮合二環式ヘテロアリール誘導体

Country Status (31)

Country Link
US (1) US10287286B2 (enExample)
EP (1) EP3271357B1 (enExample)
JP (1) JP6726681B2 (enExample)
KR (1) KR102609431B1 (enExample)
CN (1) CN107531698B (enExample)
AU (1) AU2016234209B2 (enExample)
BR (1) BR112017019653B1 (enExample)
CA (1) CA2979024C (enExample)
CL (1) CL2017002354A1 (enExample)
CO (1) CO2017009353A2 (enExample)
CR (1) CR20170468A (enExample)
DK (1) DK3271357T3 (enExample)
DO (1) DOP2017000209A (enExample)
EA (1) EA035739B1 (enExample)
EC (1) ECSP17069696A (enExample)
ES (1) ES2774052T3 (enExample)
GB (1) GB201504565D0 (enExample)
GE (2) GEAP201914608A (enExample)
HU (1) HUE047918T2 (enExample)
IL (1) IL254277B (enExample)
MX (1) MX2017011902A (enExample)
MY (1) MY194873A (enExample)
NZ (1) NZ735631A (enExample)
PE (1) PE20180656A1 (enExample)
PH (1) PH12017501699B1 (enExample)
PT (1) PT3271357T (enExample)
SG (1) SG11201707280VA (enExample)
TN (1) TN2017000384A1 (enExample)
UA (1) UA123668C2 (enExample)
WO (1) WO2016148306A1 (enExample)
ZA (1) ZA201706612B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2794779T3 (es) 2016-02-24 2020-11-19 Pfizer Derivados de pirazolo[1,5-a]pirazin-4-ilo como inhibidores de JAK
EP3668858A1 (en) 2017-08-14 2020-06-24 Pfizer Inc Pyrazolo[1,5-a]pyrazin-4-yl and related derivatives
PL3808747T3 (pl) * 2018-09-13 2025-03-17 Kissei Pharmaceutical Co., Ltd. Związek imidazopirydynonowy
CN110950806A (zh) * 2019-11-14 2020-04-03 安庆博曼生物技术有限公司 四乙基氯化铵催化嘧啶环羟基氯代制备方法
JP7504822B2 (ja) * 2020-03-12 2024-06-24 キッセイ薬品工業株式会社 イミダゾピリジノン化合物を含む医薬組成物
US11718622B2 (en) 2020-03-16 2023-08-08 Exelixis Inc. Heterocyclic adenosine receptor antagonists
WO2021213380A1 (zh) * 2020-04-20 2021-10-28 深圳市塔吉瑞生物医药有限公司 吡嗪取代的烟酰胺的固体形式及其制备和用途
MX2023004518A (es) * 2020-10-20 2023-06-19 Amgen Inc Compuestos espiro heterocíclicos y métodos de uso.
US12492178B2 (en) 2021-09-01 2025-12-09 Empathbio, Inc. Stable polymorph of R-MDMA HCl
AR127488A1 (es) 2021-10-28 2024-01-31 Insilico Medicine Ip Ltd Inhibidores de la proteína que contiene el dominio de prolil hidroxilasa (phd) y usos de los mismos
EP4447963A1 (en) * 2021-12-17 2024-10-23 Akebia Therapeutics Inc. Selective phd1 inhibitor compounds, compositions, and methods of use
US11912680B2 (en) 2021-12-28 2024-02-27 Empathbio, Inc. Nitric oxide releasing prodrugs of MDA and MDMA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209621A (en) 1979-04-27 1980-06-24 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-a]-pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-a]pyrimidines
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
DK135184A (da) * 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
JP2004502691A (ja) 2000-06-30 2004-01-29 ワイス 抗癌薬としての置換トリアゾロピリミジン
JP2010065026A (ja) 2008-08-13 2010-03-25 Ishihara Sangyo Kaisha Ltd ピリジル−トリアゾロピリミジン誘導体又はその塩、並びにそれらを含有する有害生物防除剤
JP2010065024A (ja) 2008-08-14 2010-03-25 Ishihara Sangyo Kaisha Ltd トリアゾロピリミジン誘導体又はその塩を含有する有害生物防除剤
PT2455381E (pt) * 2009-07-17 2014-06-24 Japan Tobacco Inc Composto de triazolopiridina e sua acção como inibidor da prolil-hidroxilase e indutor da produção de eritropoietina
JP2011168582A (ja) * 2010-01-21 2011-09-01 Ishihara Sangyo Kaisha Ltd トリアゾロピリジン誘導体又はその塩、それらの製造方法及びそれらを含有する有害生物防除剤
US20150239889A1 (en) 2012-08-23 2015-08-27 Mitsubishi Tanabe Pharma Corporation Pyrazolopyrimidine compound

Similar Documents

Publication Publication Date Title
JP2021502356A5 (enExample)
JP2017530999A5 (enExample)
JP2023525762A5 (enExample)
JP2010513283A (ja) 新規なオキサジアゾール化合物
RU2012104493A (ru) Замещенные соединения пиразоло [1,5-a] пиримидина как ингибиторы киназы trk
RU2016141645A (ru) ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ
RU2017116598A (ru) Соединения и композиции для модуляции киназной активности мутантов egfr
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
RU2017135520A (ru) Бициклические производные хиназолинона
JP2016517878A5 (enExample)
JP2010510319A5 (enExample)
JP2008516982A5 (enExample)
JP2019515931A5 (enExample)
JP2019512482A5 (enExample)
RU2012143794A (ru) Производные n-(имидазопиримидин-7-ил)-гетероаламидов и их применение в качестве ингибиторов pde10a
GB2609879A (en) Antagonists of the adenosine A2a receptor
RU2015112580A (ru) Ингибиторные соединения
CA2610888A1 (en) Inhibitors of akt activity
RU2019132212A (ru) Селективные ингибиторы hdac6
HRP20140770T1 (hr) SUPSTITUIRANI SPOJEVI N-(1H-INDAZOL-4-IL)IMIDAZO[1,2-a]PIRIDIN-3-KARBOKSAMIDA KAO INHIBITORI CFMS
RU2006134021A (ru) Производные гетероарил-конденсированного пиразола
JP2017512794A5 (enExample)
CN103857392A (zh) 用于治疗增生性疾病的2-甲酰胺环氨基尿素衍生物与Hsp90抑制剂的组合
JP2017508766A5 (enExample)